Axsome Therapeutics, Inc. Equity-NMS: AXSM

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$107.89
Open :$105.34
Today's high :$106.28
Today's low :$98.8
52W low :$64.11
52W high :$139.1299
EPS(TTM): :-5.99
Shares O/S :48.77 M
Market cap :4.82 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Axsome Therapeutics, Inc. $98.86 -6.51% - 4.82B

Frequently Asked Questions

What is the share price of Axsome Therapeutics, Inc. today?

Axsome Therapeutics, Inc. (AXSM) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity under development for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. AXS-07 is an oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine.